| abstract |
The present application relates to compounds of formula (I) wherein Cy, R1-R3, R4A and R4B are defined as described herein, and pharmaceutically acceptable salts and solvates thereof. For objects. The present invention is also directed to the use of compounds of formula (I) to treat disorders responsive to modulation of one or more opioid receptors, or as synthetic intermediates. Certain compounds of the present invention are particularly useful for treating pain. Embedded image |